BS

Bhushan Shridhar Pansare

Active Director Director DIN 10823194
DIN 10823194 First appointment Nov 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Bhushan Shridhar Pansare

Data last updated:

Bhushan Shridhar Pansare is a Director at Curexa Pharma Private Limited (since 2024).

DIN 10823194
Primary Designation Director
First Appointment 18 Nov 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Curexa Pharma Private Limited U47721PN2024PTC234094
Director18 Nov 20242024Active

Board colleagues of Bhushan Shridhar Pansare

Directorship timeline

Open interactive timeline →
Curexa Pharma Private Limited
Premium access

Shareholding and investment profile for Bhushan Shridhar Pansare

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bhushan Shridhar Pansare

Bhushan Shridhar Pansare currently holds 1 directorship: Curexa Pharma Private Limited (Director, since 18 Nov 2024).

Bhushan Shridhar Pansare was first appointed on 18 Nov 2024 as Director at Curexa Pharma Private Limited.

The current boards of Bhushan Shridhar Pansare's companies include Hemant Balasaheb Patil (Curexa Pharma Private Limited), Nilesh Ananda Patil (Curexa Pharma Private Limited), Sachin Ananda Takale (Curexa Pharma Private Limited), Sandipkumar Dashrath Shipate (Curexa Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available